- Spermatozoïdes Testiculaires
- Published:
Comment identifier le spermatozoïde vivant?
How to identify living spermatozoa?
Andrologie volume 12, pages 332–341 (2002)
Resume
Les spermatozoïdes testiculaires ont une mobilité souvent diminuée voire nulle qui est considérablement altérée par le processus de congélation-décongélation. La difficulté, face à des spermatozoïdes immobiles, est de faire la distinction entre un spermatozoïde vivant et un spermatozoïde mort. La plupart des test de vitalité spermatique explore l’intégrité fonctionnelle et structurale de la membrane plasmique, comme les tests d’exclusion des colorants vitaux ou le test de gonflement hypo-osmotique.
La mobilité spermatique est le seul paramètre qui permet d’avoir la certitude de la vitalité spermatique. Nous avons évalué les effets de la Pentoxifylline (PTX), inhibiteur de la phosphodiestérase de l’AMPc, sur les spermatozoïdes testiculaires décongelés (n=14), afin de démontrer que ce stimulant chimique est capable d’induire ou d’augmenter leur mobilité. La PTX augmente significativement le nombre de spermatozoïdes testiculaires mobiles après décongélation dans les prélèvements de patients présentant une azoospermie sécrétoire (n=8) ou excrétoire (n=6). L’action maximale est atteinte entre 60 et 120 minutes. L’effet de la PTX sur la mobilité est supérieure lorsque les spermatozoïdes sont issus de sujets présentant une azoospermie excrétoire. L’association PTX-gradient de migration amplifie cet effet sur la mobilité dans les prélèvements d’origine excrétoire. Cet effet cumulatif n’est pas observé sur les spermatozoïdes des azoospermies sécrétoires.
Sur les 100 cycles d’ICSI réalisés à l’aide de spermatozoïdes testiculaires ou épididymaires décongelés et traités par la PTX à 3,5mM, aucune différence significative n’a été observée entre les taux de fécondation, le nombre d’embryons obtenus, transférés ou congelés ainsi que les taux de grossesse entre les cycles d’ICSI utilisant des spermatozoïdes testiculaires des azoospermies sécrétoires et ceux des azoospermies excrétoires.
Le Pentoxifylline, en induisant et augmentant la mobilité des spermatozoïdes testiculaires décongelés, facilite la sélection des spermatozoïdes vivants en vue de leur utilisation ultérieure.
Abstract
Testicular sperm extraction (TESE) has been used to retrieve spermatozoa in patients with secretory azoospermia for intracytoplasmic sperm injection (ICSI). However, testicular spermatozoa have poor motility that significantly decreases after cryopreservation and thawing. The major difficulty with testicular spermatozoa is to distinguish between living and dead spermatozoa, as most spermatozoa are immotile. The aim of this study was firstly to report the various methods used to explore spermatozoa vitality. Most tests assess the functional and structural integrity of the sperm membrane, such as staining methods and hypo-osmotic swelling test (HOS-test). We then evaluates the potential of pentoxifylline (PTX), a phosphodiesterase inhibitor of the methylxanthine group, to improve the distinction between living and dead immotile testicular spermatozoa by increasing the number of post-thawed motile spermatozoa. We also analysed the results of 100 ICSI cycles performed with frozen-thawed testicular (n=72) and epididymal (n=28) spermatozoa treated with 3.5 mM PTX.
To test the effect of PTX on motility, 14 samples of frozen-thawed testicular spermatozoa from eight patients with secretory azoospermia and six patients with excretory azoospermia were divided into three equal samples: one sample treated with 3.5 mM PTX, one sample initially migrated on two-layer Percoll gradient and then divided into two aliquots (one treated with 3.5 mM PTX, one without treatment), and the last sample without migration and without PTX treatment. The number of motile spermatozoa was evaluated in 10 μL of each sample with an inverted microscope at 15, 30, 60, 120 minutes and 24 hours. We also compared the outcome of ICSI in 100 cycles using frozen-thawed epididymal or testicular spermatozoa between secretory and excretory patients.
PTX significantly increased the number of motile frozen-thawed testicular spermatozoa in secretory and excretory azoospermia. In excretory azoospermia, the number of motile spermatozoa was further increased when PTX was associated with migration on Percoll gradient, while PTX alone gave the best results in secretory azoospermia. Fertilization and pregnancy rates as well as embryo quality and division stages were comparable in the two groups.
By increasing the number of motile frozen-thawed testicular spermatozoa, PTX improves the selection of living spermatozoa.
References
AHMADI A., NG S.C.: The single sperm curling test, a modified hypo-osmotic swelling test, as a potential technique for the selection of viable sperm for intracytoplasmic sperm injection. Fertil. Steril., 1997, 68: 346–355.
ANGELOPOULOS T., ADLER A., KREY L., LICCIARDI F., NOYES N., MC CULLOUGH A.: Enhancement or initiation of testicular sperm motility byin vitro culture of testicular tissue. Fertil. Steril., 1999, 71: 240–243.
AVIADO D.M., PORTER J.M.: Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy, 1984, 4: 297–307.
BACHTELL N.E., CONAGHAN J., TUREK P.J.: The relative viability of human spermatozoa from the vas deferens, epididymis and testis before and after cryopreservation. Hum. Reprod., 1999, 14: 3048–3051.
CALAMERA J., DE VINCENTIIS S., NODAR F., FISZBAJN G., CHILLIK C., BRUGO-OLMEDO S.: Impact of cryopreservation on sperm motility and pentoxifylline efficiency on fresh and cryopreserved immotile sperm obtained from azoospermic patients. 18th annual meeting of the ESHRE, Vienna, Austria 2002.
CASPER R.F., MERIANO J.S., JARVI K.A., COWAN L., LUCATO M.L.: The hypo-osmotic swelling test for selection of viable sperm for intracytoplasmic sperm injection in men with complete asthenozoospermia. Fertil. Steril., 1996, 65: 972–976.
CHENG C.Y., BOETTCHER B.: The effect of steroids on thein vitro migration of washed human spermatozoa in modified Tyrode’s solution or in fasting human blood serum. Fertil. Steril., 1979, 32: 566–570.
CENTOLA G.M., CARTIE R.J., COX C.: Differential responses of human sperm to varying concentrations of pentoxyfylline with demonstration of toxicity. J. Androl., 1995, 16: 136–142.
EDIRISINGHE W.R., JUNK S.M., MATSON P.L., YOVICH J.L.: Changes in motility patterns during in-vitro culture of fresh and frozen/thawed testicular and epididymal spermatozoa: implications for planning treatment by intracytoplasmic sperm injection. Hum. Reprod., 1996, 11: 2474–2476.
EMILIANI S., VAN DEN BERGH M., VANNIN A.S., BIRAMANE J., VERDOODT M., ENGLERT Y.: Increased sperm motility after in-vitro culture of testicular biopsies from obstructive azoospermic patients results in better post-thaw recovery rate. Hum. Reprod., 2000, 15: 2371–2374.
ESTEVES S.C., SHARMA R.K., THOMAS A.J. JR, AGARWAL A.: Suitability of the hypo-osmotic swelling test for assessing the viability of cryopreserved sperm. Fertil. Steril., 1996, 66: 798–804.
GIL-SALOM M., ROMERO J., MINGUEZ Y. et al.: Pregnancies after intracytoplasmic sperm injection with cryopreserved testicular spermatozoa. Hum. Reprod., 1996, 11: 1309–1313.
HAMMITT D.G., BEDIA E., ROGERS P.R., SYROP C.H., DONOVAN J.F., WILLIAMSON R.A.: Comparison of motility stimulants for cryopreserved human semen. Fertil. Steril., 1989, 52: 495–502.
IDAOMAR M., GUERIN J.F., LORNAGE J., CZYBA J.C.: Stimulation of motility and energy metabolism of spermatozoa from asthenozoospermic patients by 17 beta-estradiol. Arch. Androl., 1989, 22: 197–202.
JEYENDRAN R.S., VAN DER VEN H.H., PEREZ-PELAEZ M., CRABO B.G., ZANEVELD L.J.: Development of an assay to assess the functional integrity of the human sperm membrane and its relationship to other semen characteristics. J. Reprod. Fertil., 1984, 70: 219–228.
JEYENDRAN R.S., VAN DER VEN H.H., ZANEVELD L.J.: The hypoosmotic swelling test: an update. Arch. Androl., 1992, 29: 105–116.
KAY V.J., COUTTS J.R., ROBERTSON L.: Pentoxifylline stimulates hyperactivation in human spermatozoa. Hum. Reprod., 1993, 8: 727–731.
LEAZER T.M., DASTON G.P., KEEN C., ROGERS J.M.: Lipopolysaccharide (LPS)-induced embryo lethality in the CD-1 mouse: Effects of inhibition of tumor necrosis-alpha (TNF-alpha). Teratology, 1998, 57: 235.
LEVY R.: Apotose au cours de la spermatogenèse et dans le sperme éjaculé. Andrologie, 1999, 3: 449–458.
LIN M.H., MORSHEDI M., SRISOMBUT C., NASSAR A., OEHNINGER S.: Plasma membrane integrity of cryopreserved human sperm: an investigation of the results of the hypoosmotic swelling test, the water test, and eosin-Y staining. Fertil. Steril., 1998, 70: 1148–1155.
LOMEO A.M., GIAMBERSIO A.M.: “Water-test”: a simple method to assess sperm-membrane integrity. Int. J. Androl., 1991, 14: 278–282.
NAGY Z.P., LIU J., JORIS H. et al.: The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum. Reprod., 1995, 10: 1123–1129.
NAGY Z., LIU J., CECILE J. et al.: Using ejaculated, fresh, and frozen-thawed epididymal and testicular spermatozoa gives rise to comparable results after intracytoplasmic sperm injection. Fertil. Steril., 1995, 63: 808–815.
NAGY Z.P., JORIS H., VERHEYEN G., TOURNAYE H., DEVROEY P., VAN STEIRTEGHEM A.C.: Correlation between motility of testicular spermatozoa, testicular histology and the outcome of intracytoplasmic sperm injection. Hum. Reprod., 1998, 13: 890–895.
NASSAR A., MORSHEDI M., MAHONY M., SRISOMBUT C., LIN M.H., OEHNINGER S.: Pentoxifylline stimulates various sperm motion parameters and cervical mucus penetrability in patients with asthenozoospermia. Andrologia, 1999, 31: 9–15.
PALERMO G., JORIS H., DEVROEY P., VAN STEIRTEGHEM A.C.: Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet, 1992, 340: 17–18.
PANG S.C., CHAN P.J., LU A.: Effects of pentoxifylline on sperm motility and hyperactivation in normozoospermic and normokinetic semen. Fertil. Steril., 1993, 60: 336–343.
PRINS G.S., DOLGINA R., STUDNEY P., KAPLAN B., ROSS L., NIEDERBERGER C.: Quality of cryopreserved testicular sperm in patients with obstructive and nonobstructive azoospermia. J. Urol., 1999, 161: 1504–1508.
RIVES N., SIBERT L., CLAVIER B., DELABROYE V., MARPEAU L., MACE B.: Full-term delivery following intracytoplasmic sperm injection with frozen-thawed immotile testicular spermatozoa. Hum. Reprod., 1998, 13: 3399–3401.
SCHLEGEL P.N., SU L.M.: Physiological consequences of testicular sperm extraction. Hum. Reprod., 1997, 12: 1688–1692.
SHULMAN A., FELDMAN B., MADGAR I., LEVRON J., MASHIACH S., DOR J.: In-vitro fertilization treatment for severe male factor: the fertilization potential of immotile spermatozoa obtained by testicular extraction. Hum. Reprod., 1999, 14: 749–752.
SCOTT L., SMITH S.: Human sperm motility-enhancing agents have detrimental effects on mouse oocytes and embryos. Fertil. Steril., 1995, 63: 166–175.
SION B., GRIZARD G., BOUCHER D., JANNY L.: Annexin V binding to plasma membrane predicts the outcome of cryopreservation of human sperm. 18th annual meeting of the ESHRE, Vienna, Austria 2002.
STEELE E.K., MC CLURE N., MAXWELL R.J., LEWIS S.E.: A comparison of DNA damage in testicular and proximal epididymal spermatozoa in obstructive azoospermia. Mol. Hum. Reprod., 1999, 5: 831–835.
TASDEMIR I., TASDEMIR M., TAVUKCUOGLU S.: Effect of pentoxifylline on immotile testicular spermatozoa. J. Assist. Reprod. Genet., 1998, 15: 90–99.
TASDEMIR M., TASDEMIR I., KODAMA H., TANAKA T.: Pentoxifylline-enhanced acrosome reaction correlates with fertilizationin vitro. Hum. Reprod., 1993, 8: 2102–2107.
TERRIOU P., HANS E., GIORGETTI C., et al.: Pentoxifylline initiates motility in spontaneously immotile epididymal and testicular spermatozoa and allows normal fertilization, pregnancy, and birth after intracytoplasmic sperm injection. J. Assist. Reprod. Genet., 2000, 17: 194–199.
TESARIK J., THEBAULT A., TESTART J.: Effect of pentoxifylline on sperm movement characteristics in normozoospermic and asthenozoospermic specimens. Hum. Reprod., 1992, 7: 1257–1263.
TOURNAYE H., VAN STEIRTEGHEM A.C., DEVROEY P.: Pentoxifylline in idiopathic male-factor infertility: a review of its therapeutic efficacy after oral administration. Hum. Reprod., 1994, 9: 996–1000.
WHO: WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th edn, Cambridge University Press, Cambridge UK, 1999.
WANG C.W., LAI Y.M., WANG M.L., LEE J.D., SOONG Y.K.: Pregnancy after intracytoplasmic injection of immotile sperm. A case report. J. Reprod. Med., 1997, 42: 448–450.
VERHEYEN G., JORIS H., CRITS K., NAGY Z., TOURNAYE, H., VAN STEIRTEGHEM A.: Comparison of different hypoosmotic swelling solutions to select viable immotile spermatozoa for potential use in intracytoplasmic sperm injection. Hum. Reprod. Update, 1997, 3: 195–203.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rives, N., Sibert, L., Mazurier, S. et al. Comment identifier le spermatozoïde vivant?. Androl. 12, 332–341 (2002). https://doi.org/10.1007/BF03034650
Issue Date:
DOI: https://doi.org/10.1007/BF03034650